Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer

Nutrition and Cancer

Volumn 67, Issue 3, 2015, Pages 472-480

  Wesseltoft Rao, Nima ^a,b   Hjermstad, Marianne J ^c,d   Ikdahl, Tone ^c   Dajani, Olav ^c   Ulven, Stine M ^a   Iversen, Per Ole ^b,c   Bye, Asta ^a,b  

^a OSLO METROPOLITAN UNIVERSITY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CACHEXIA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; DIETARY INTAKE; FEMALE; FOOD INTAKE; HUMAN; MALE; OVERALL SURVIVAL; PANCREAS CANCER; SARCOPENIA; SELF REPORT; VERY ELDERLY; WEIGHT REDUCTION; CLASSIFICATION; MIDDLE AGED; MORTALITY; PANCREAS TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CACHEXIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84926520477     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1004728     Document Type: Article

References (34)

1. Fearon K, Strasser F, Anker SD, Boseaus I, Bruera E, et al.: Definition and classification of cancer cachexia: n international consensus. The Lancet Oncology 12, 489-495, 2011.
2. Blum D and Strasser F: Cachexia assessment tools. Current Opinion in Supportive & Palliative Care 5, 350-355, 2011.
3. Vigano A, Del Fabbro E, Bruera E, and Borod M: The cachexia clinic: from staging to managing nutritional and functional problems in advanced cancer patients. Crit Rev Oncog 17, 293-303, 2012.
4. Fearon KC: Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 44, 1124-1132, 2008.
5. Bozzetti F and Mariani L: Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. J Parenter Enteral Nutr 33, 361-367, 2009.
6. Evans WJ, Morley JE, Argiles J, Beles C, Baracos V, et al.: Cachexia: a new definition. Clin Nutr 27, 793-799, 2008.
7. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, et al.: Consensus definition of sarcopenia, cachexia and precachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-Anorexia in chronic wasting diseases" and "nutrition in geriatrics." Clin Nutr 29, 154-159, 2010.
8. Fox KM, Brooks JM, Gandra SR, Markus R, and Chiou CF: Estimation of cachexia among cancer patients based on four definitions. Journal of Oncology 2009, 1-7, 2009. doi:10.1155/2009/693458
9. Fearon KC, Voss AC, and Hustead DS: Cancer Cachexia Study Group: Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83, 1345-1350, 2006.
10. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB et al.: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a populationbased study. Lancet Oncol 9, 629-635, 2008.
11. Janssen I, Heymsfield SB, and Ross R: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50, 889-896, 2002.
12. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, et al.: Epidemiology of sarcopenia among the elderly in New Mexico. American Journal of Epidemiology 47, 755-763, 1998.
13. Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, et al.: Validation of the consensus-definition for cancer cachexia and evaluation of a classification model-A study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol 25, 1635-1642, 2014. doi:10.1093/annonc/mdu086
14. Van der Meij BS, Schoonbeek CP, Smit EF, Muscaritoli M, Van Leeuwen PA, et al.: Pre-cachexia and cachexia at diagnosis of stage III non-smallcell lung carcinoma: an exploratory study comparing two consensusbased frameworks. Br J Nutr 109, 1-9, 2012.
15. Wallengren O, Lundholm K, and Bosaeus I: Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer 21, 1569-1577, 2013.
16. Fearon KC, Barber MD, Falconer JS, McMillan DC, Ross JA, et al.: Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg 23, 584-588, 1999.
17. Wigmore SJ, Plester CE, Richardson RA, and Fearon KC: Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75, 106-109, 1997.
18. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, et al.: What is subjective global assessment of nutritional status? J Parenter Enteral Nutr 11, 8-13, 1987.
19. Blum D, Omlin A, Baracos VE, Solheim TS, Tan BHL, et al.: Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer. Critical Reviews in Oncology/Hematology 80, 114-144, 2011.
20. Deans DA, Tan BH, Wigmore SJ, Ross JA, De Beaux AC, et al.: The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 100, 63-69, 2009.
21. Thoresen L, Fjeldstad I, Krogstad K, Kaasa S, and Falkmer UG: Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med 16 (1), 33-42, 2002.
22. Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, and Antoun S: Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 91, 1133S-1137S, 2010.
23. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, et al.: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33, 997-1006, 2008.
24. Prado CM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, et al.: Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13, 3264-3268, 2007.
25. Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, et al.: Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clin Nutr 32, 65-72, 2013.
26. Blauwhoff-Buskermolen S, De van der Schueren MA, Verheul HM, and Langius JA: "Pre-cachexia": a non-existing phenomenon in cancer? Ann Oncol 2014. pii: mdu178. PMID: 24827129
27. Thompson FE, and Subar AF: Dietary assessment methodology. In: Nutrition in the Prevention and Treatment of Disease, 3rd ed., Coulston AM, & Boushey CJ (eds.). Burlington: Academic Press, 2008, 2-39.
28. Solheim TS, Blum D, Fayers PM, Hjermstad MJ, Stene GB, et al.: Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: Three peas in a pod? Analysis from a multicenter cross sectional study. Acta Oncol 53, 539-546, 2013.
29. Di Sebastiano KM, Yang L, Zbuk K, Wong RK, Chow T, et al.: Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr 109, 302-312, 2013.
30. Barber MD, Ross JA, and Fearon KC: Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35, 106-110, 1999.
31. Blum D, Omlin A, Fearon K, Baracos V, Radbruch L, et al.: Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer 18, 273-279, 2010.
32. Sergi G, Perissinotto E, Pisent C, Buja A, Maggi S, et al.: An adequate threshold for body mass index to detect underweight condition in elderly persons: the Italian Longitudinal Study on Aging (ILSA). The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60, 866-871, 2005.
33. Jackson AS, Janssen I, Sui X, Church TS, and Blair SN: Longitudinal changes in body composition associated with healthy ageing: men, aged 20-96 years. Br J Nutr 107, 1085-1091, 2012.
34. Tan BH, Birdsell LA, Martin L, Baracos VE, and Fearon KC: Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15, 6973-6979, 2009.